LLY

1,050.46

+0.71%↑

JNJ

203.51

+1.27%↑

ABBV

230.92

-2.3%↓

UNH

310.01

+0.28%↑

AZN

89.76

+0.09%↑

LLY

1,050.46

+0.71%↑

JNJ

203.51

+1.27%↑

ABBV

230.92

-2.3%↓

UNH

310.01

+0.28%↑

AZN

89.76

+0.09%↑

LLY

1,050.46

+0.71%↑

JNJ

203.51

+1.27%↑

ABBV

230.92

-2.3%↓

UNH

310.01

+0.28%↑

AZN

89.76

+0.09%↑

LLY

1,050.46

+0.71%↑

JNJ

203.51

+1.27%↑

ABBV

230.92

-2.3%↓

UNH

310.01

+0.28%↑

AZN

89.76

+0.09%↑

LLY

1,050.46

+0.71%↑

JNJ

203.51

+1.27%↑

ABBV

230.92

-2.3%↓

UNH

310.01

+0.28%↑

AZN

89.76

+0.09%↑

Начало・Списък с акции・Vaxart Inc

Vaxart Inc

Отворен

0.32

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

0.32

Максимум

0.32

Ключови измерители
By Trading Economics
Приходи	6.8M -8.1M
Продажби	33M 72M
EPS	-0.04
Марж на печалбата	-11.242
Служители	105
EBITDA	6.5M -5.6M

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-2.5M 89M
Предишно отваряне	0.32
Предишно затваряне	0.32

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

0.4007 / 0.4252 Подкрепа & съпротива

Vaxart Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

19.11.2025 г., 23:36 ч. UTC

Горещи акции

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

19.11.2025 г., 22:13 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

19.11.2025 г., 21:55 ч. UTC

Значими двигатели на пазара

Amgen Lung Cancer Drug Gets Full Approval From FDA

19.11.2025 г., 21:43 ч. UTC

Придобивния, сливания и поглъщания

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

19.11.2025 г., 23:55 ч. UTC

Пазарно говорене

Gold Rises on Possible Investment Demand -- Market Talk

19.11.2025 г., 23:54 ч. UTC

Пазарно говорене

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

19.11.2025 г., 23:47 ч. UTC

Печалби

Lenovo Group 2Q EPS $2.52 >0992.HK

19.11.2025 г., 23:46 ч. UTC

Печалби

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

19.11.2025 г., 23:45 ч. UTC

Печалби

Lenovo Group 2Q Rev $20.5B >0992.HK

19.11.2025 г., 23:42 ч. UTC

Пазарно говорене

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

19.11.2025 г., 23:42 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

19.11.2025 г., 23:41 ч. UTC

Печалби

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

19.11.2025 г., 23:41 ч. UTC

Печалби

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

19.11.2025 г., 23:40 ч. UTC

Печалби

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

19.11.2025 г., 22:55 ч. UTC

Печалби

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

19.11.2025 г., 22:41 ч. UTC

Печалби

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

19.11.2025 г., 22:30 ч. UTC

Придобивния, сливания и поглъщания

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

19.11.2025 г., 22:30 ч. UTC

Печалби

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

19.11.2025 г., 22:30 ч. UTC

Придобивния, сливания и поглъщания

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

19.11.2025 г., 22:27 ч. UTC

Придобивния, сливания и поглъщания

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

19.11.2025 г., 22:08 ч. UTC

Печалби

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

19.11.2025 г., 22:00 ч. UTC

Печалби

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

19.11.2025 г., 21:58 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

19.11.2025 г., 21:52 ч. UTC

Печалби

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

19.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

19.11.2025 г., 21:49 ч. UTC

Пазарно говорене

Печалби

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

19.11.2025 г., 21:38 ч. UTC

Печалби

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

19.11.2025 г., 21:28 ч. UTC

Придобивния, сливания и поглъщания

Palo Alto Networks to Buy Chronosphere for $3.35B

19.11.2025 г., 21:27 ч. UTC

Придобивния, сливания и поглъщания

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

19.11.2025 г., 21:24 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Сравнение с други в отрасъла

Ценова промяна

Vaxart Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Vaxart Inc през последните 3 месеца.

Техническа оценка

By Trading Central

0.4007 / 0.4252Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.